Cargando…

A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies

Novel ADCC effector cells expressing the V-variant or F-variant of FcγRIIIa (CD16a) and firefly luciferase under the control of a chimeric promoter incorporating recognition sequences for the principal transcription factors involved in FcγRIIIa signal transduction, together with novel target cells o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lallemand, Christophe, Liang, Feifei, Staub, Flore, Simansour, Maud, Vallette, Benoit, Huang, Lue, Ferrando-Miguel, Rosa, Tovey, Michael G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635472/ https://www.ncbi.nlm.nih.gov/pubmed/29104875 http://dx.doi.org/10.1155/2017/3908289

Ejemplares similares

The Yin and Yang of ADCC-Mediating Antibodies
por: Robert-Guroff, Marjorie
Publicado: (2016)

Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma
por: Lallemand, Christophe, et al.
Publicado: (2020)

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
por: Iida, Shigeru, et al.
Publicado: (2009)

Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC
por: Natsume, Akito, et al.
Publicado: (2009)

Glycoengineering of AAV-delivered monoclonal antibodies yields increased ADCC activity
por: Termini, James M., et al.
Publicado: (2020)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
por: Mielke, Dieter, et al.
Publicado: (2019)

Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.
por: Pehamberger, H., et al.
Publicado: (1980)

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes
por: Pollara, J, et al.
Publicado: (2012)

ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
por: Semmes, Eleanor C., et al.
Publicado: (2023)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
por: Khanna, Vidhi, et al.
Publicado: (2021)

Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC)
por: Jäpel, M., et al.
Publicado: (1994)

Antibody subclass skewing predicts enhanced ADCC activity in both natural infection and vaccination
por: Dugast, A, et al.
Publicado: (2012)

“Universal Flu Vaccine”: Can NK Cell-mediated ADCC Tip the Scales?
por: Hassane, Maya, et al.
Publicado: (2016)

Development of a Macrophage-Based ADCC Assay
por: Uccellini, Melissa B., et al.
Publicado: (2021)

Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses
por: Pollara, Justin, et al.
Publicado: (2013)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
por: Dixon, Kate J., et al.
Publicado: (2021)

Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirus
por: Vlahava, Virginia-Maria, et al.
Publicado: (2021)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
por: Yaffe, Zak A., et al.
Publicado: (2023)

Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
por: Li, Feifei, et al.
Publicado: (2022)

ADCC potency assay: increased standardization with modified lymphocytes
por: Bretaudeau, Laurent, et al.
Publicado: (2011)

γδT cells are ADCC effectors in elite HIV controllers
por: Poonia, Bhawna, et al.
Publicado: (2010)

ADCC: An underappreciated correlate of cross-protection against influenza?
por: de Vries, Rory D., et al.
Publicado: (2023)

Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC Antibodies
por: Parsons, Matthew S., et al.
Publicado: (2015)

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
por: Roßkopf, Sophia, et al.
Publicado: (2020)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
por: Mielke, Dieter, et al.
Publicado: (2021)

Safety, Tolerability, and Immunogenicity of Interferons
por: Tovey, Michael G., et al.
Publicado: (2010)

Using impedance-based approaches for measuring cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC)
por: Lamarche, Brandon, et al.
Publicado: (2015)

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
por: Tso, For Yue, et al.
Publicado: (2021)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
por: Mabuka, Jennifer, et al.
Publicado: (2012)

Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
por: Aziz, Mariam, et al.
Publicado: (2015)

The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein
por: Chen, Xuemin, et al.
Publicado: (2021)

1008. Presence of Antibody Dependent Cell Cytotoxicity (ADCC) Functional Antibodies that Target a Complex Gp41 Epitope Correlates with Long-term Non-progression and ADCC is Maintained with Mutants Using Germline Heavy Chain Variable Gene Sequence of VH1-02 Gene
por: Baron, Sarah, et al.
Publicado: (2021)

A Novel CRYBB2 Silent Variant in Autosomal Dominant Congenital Cataracts (ADCC) in Pakistani families
por: Hussain, Maryam, et al.
Publicado: (2023)

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
por: Decaup, Emilie, et al.
Publicado: (2019)

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART)
por: Jensen, Sanne Skov, et al.
Publicado: (2015)

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement
por: Kline, James Bradford, et al.
Publicado: (2017)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
por: Parsons, MS, et al.
Publicado: (2012)

Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies
por: Pham, Tram N. Q., et al.
Publicado: (2016)

ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
por: Kol, Arjan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c0is8b19ead5cul0ncblad4umm